Table 1.
Diagnostic findings in study groups
| GROUP A (n = 28; 67%) |
GROUP B (n = 14; 33%) |
||
|---|---|---|---|
| LGE PATTERN | Global subendocardial (n; %) | 18 (64%) | 0 |
| Global subendocardial, focally or globally transmural (n; %) |
10 (36%) | 0 | |
| Midwall (n;%) | 0 | 6 (43%) | |
| Atrial walls (n;%) | 25 (89%) | 3 (21%) | |
| Subepicardial, pericardial (n;%) | 0 | 2 (14%) | |
| Accelerated contrast wash-out (n;%) | 23 (82%) | 0 | |
| No LGE (n;%) | 0 | 3 (21%) | |
| EMB | Negative (n;%) | 1 (3%) | 10 (71%) |
| Positive (n;%) | 9 (32%) [8 AL, 1 WT ATTR] | 1 (7%) [WT ATTR] | |
| NP (n;%) | 18 (64%) | 3 (21%) | |
| GA | Negative (n;%) | 10 (35%) | 6 (42%) |
| Positive (n;%) | 4 (14%) | 0 | |
| NP (n;%) | 14 (50%) | 8 (57%) | |
LGE late gadolinium enhancement, EMB endomyocardial biopsy, GA genetic analysis, AL amyloid light chain, WT wild type, ATTR transthyretin-related, NP not performed